A rare and fatal cause of hypertrophic cardiomyopathy: Danon disease

Cardiol Young. 2023 Aug;33(8):1448-1450. doi: 10.1017/S1047951122004164. Epub 2023 Jan 5.

Abstract

Danon disease is a rare and fatal disease caused by a mutation in the lysosome-associated membrane protein 2 gene. Impaired intracellular autophagy causes lysosomal vacuoles to accumulate mainly in myocardial and skeletal muscle cells, leading to hypertrophic cardiomyopathy, skeletal myopathy, and varying degrees of intellectual disability. Two distinct childhood presentations of Danon disease are described in this report.

Keywords: Danon Disease; heart failure; hypertrophic cardiomyopathy; pre-excitation.

MeSH terms

  • Cardiomyopathy, Hypertrophic* / complications
  • Child
  • Glycogen Storage Disease Type IIb* / complications
  • Glycogen Storage Disease Type IIb* / diagnosis
  • Glycogen Storage Disease Type IIb* / genetics
  • Humans
  • Lysosomal-Associated Membrane Protein 2 / genetics
  • Lysosomal-Associated Membrane Protein 2 / metabolism
  • Mutation
  • Myocardium / metabolism

Substances

  • Lysosomal-Associated Membrane Protein 2